Award

Pathology Service Joint Venture

THE CHRISTIE NHS FOUNDATION TRUST

This public procurement record has 8 releases in its history.

Award

12 May 2025 at 14:18

Award

12 May 2025 at 14:08

Award

12 May 2025 at 14:00

Award

12 May 2025 at 13:59

Award

12 May 2025 at 13:58

Tender

26 Oct 2023 at 15:22

TenderUpdate

06 Feb 2023 at 15:42

Planning

02 Feb 2023 at 16:22

Summary of the contracting process

The Christie NHS Foundation Trust, located in Manchester, is seeking a new commercial partner for a joint venture to provide comprehensive pathology services. The procurement process is in the tender stage and uses a competitive dialogue method. This collaboration aims to secure an exceptional partner who can deliver high-quality pathology services that meet the needs of a specialised cancer centre. The contract, valued at £240,000,000, spans an initial term of 15 years, with an option to extend up to 5 more years. Key dates include the tender process closing on 27th November 2023, with invitations for the second stage being sent on 11th December 2023. The services are specifically targeted to support translational biomarker development and the development of world-class infrastructure in the UKD3 region.

This tender presents significant opportunities for businesses that specialise in high-quality pathology services, infrastructure development, and research and innovation integration. Firms that possess expertise in creating scalable, technology-enhanced service models will find this opportunity appealing. Participation in this project could enhance a business's profile and offer expansion in the healthcare sector, particularly for those looking to align with strategic ambitions related to cancer care and research. With the focus on delivering a modern, thriving pathology service in collaboration with academic partners, the opportunity is ideal for businesses looking to participate in groundbreaking medical developments through a public-private partnership.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Pathology Service Joint Venture

Notice Description

The Trust has worked with a commercial partner in a joint venture (JV) arrangement to deliver a comprehensive pathology service for the last 10 years. Building on this knowledge and experience, the Trust was looking for a new partner that matches its ambitions.<br/>The initial term of the pathology service JVwill be for a period of fifteen (15) years with an option to extend by up to five (5) years.<br/>The Trust was looking for a partner that will;<br/>* Provide an exceptional, high-quality service that meets the specialist needs of a<br/>comprehensive cancer centre;<br/>* Provide investment for the provision of world class infrastructure;<br/>* Embrace the exciting opportunities presented with the co-location of a world leading<br/>oncology research centre; and<br/>* Provide expert guidance along with the creativity and drive to deliver a modern, thriving,<br/>truly exceptional pathology service for patients.

Lot Information

Lot 1

The current pathology service provides routine and specialist pathology services with c100 dedicated staff on The Christie Hospital site. The service includes translational biomarker development and supports the Trust's ambitious Research and Innovation (R&I) programme and clinical trials portfolio.

Demand for testing is increasing year on year reflecting the Trust's oncology case load. The Trust sought a JV pathology partner who is able to deliver the Trust's strategic ambitions, including accommodation of projected testing growth demand and flexible options for the development of facilities, estate, technology, and changes in clinical pathways.

Vision
To provide a world leading comprehensive pathology service that supports timely and highquality
delivery of patient care - regionally and nationally - and develops an internationally recognised workforce who, with academic and industry partners, deliver a pioneering
programme of research and innovation.

Principles/Objectives
The Future Pathology Service should reflect the following principles/objectives:

* Safe, effective, and responsive to the diversity of patient and clinical needs and offers the specialist and integrated pathology services needed to support a regional tertiary cancer centre.
* Delivery of a sustainable future pathology workforce
* alignment with the Trust's Vision and Values and the objectives of Greater Manchester Cancer.
* Commitment to working as part of Greater Manchester ICS in the delivery of the Core20PLUS5 programme to support the reduction of health inequalities at both national and system level.
* Enabled by a strong digital infrastructure and capability. Adopting digital opportunity and technology advances to deliver more efficient and scalable pathology services.
* A service model that considers The Trust's local, regional national and international partnerships, including engagement with the Greater Manchester Pathology Network to
explore opportunities to support system requirements.
* Delivered through a partnership that has a strategy for profitable growth through expanding test repertoire and customer base.
* Builds upon the Trust's reputation as an international leader in research and innovation, which is further strengthened by being a partner in the Manchester Cancer Research Centre
(MCRC) and Health Innovation Manchester.
* A service with capital investment to provide best in class facilities.
* A service that has education at its core.

The Future Operating Model for Pathology must include:

* An end-to-end comprehensive pathology service
* Blood sciences including haematology, blood transfusion, clinical biochemistry and immunoassay
* On-site essential services laboratory to support time critical and pathway critical services
* Histopathology (including immunohistochemistry and receptor analysis)
* Stem Cell Laboratory
* Point-of-Care Testing
* A future-proof design with activity growth in service expectation factored in - including expansion of on-site and off-site facilities to meet projected demand;
* An agile approach that can respond to evolving technology and operational requirements and provide improvements to the Trust Pathology Estate;
* Training, Development and Education, Research and Innovation
* Positive workplace culture
* IT infrastructure and digital enablement (including Digital Histopathology)
* Best in class equipment and instrumentation

Renewal: The proposed contract is to be let for an initial term of 180 months. There is also an option to extend the Contract by up to a further 60 months following the initial term.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-03a281
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/020567-2025
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Selective
Procurement Method Details
Competitive dialogue
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85110000 - Hospital and related services

85111800 - Pathology services

85111810 - Blood analysis services

Notice Value(s)

Tender Value
Not specified
Lots Value
£240,000,000 £100M-£1B
Awards Value
Not specified
Contracts Value
£200,000,000 £100M-£1B

Notice Dates

Publication Date
12 May 20259 months ago
Submission Deadline
27 Nov 2023Expired
Future Notice Date
30 Apr 2023Expired
Award Date
11 May 20259 months ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
THE CHRISTIE NHS FOUNDATION TRUST
Contact Name
Diane Sinclair, Ms Diane Sinclair
Contact Email
diane.sinclair@nhs.net
Contact Phone
+44 7748624560

Buyer Location

Locality
MANCHESTER
Postcode
M20 4BX
Post Town
Manchester
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD3 Greater Manchester
Small Region (ITL 3)
TLD33 Manchester
Delivery Location
TLD North West (England), TLD3 Greater Manchester

Local Authority
Manchester
Electoral Ward
Withington
Westminster Constituency
Manchester Withington

Supplier Information

Number of Suppliers
1
Supplier Name

SYNLAB

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-03a281-2025-05-12T15:18:31+01:00",
    "date": "2025-05-12T15:18:31+01:00",
    "ocid": "ocds-h6vhtk-03a281",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-03a281",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Pathology Service Joint Venture",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85111800",
            "description": "Pathology services"
        },
        "mainProcurementCategory": "services",
        "description": "The Trust has worked with a commercial partner in a joint venture (JV) arrangement to deliver a comprehensive pathology service for the last 10 years. Building on this knowledge and experience, the Trust was looking for a new partner that matches its ambitions.<br/>The initial term of the pathology service JVwill be for a period of fifteen (15) years with an option to extend by up to five (5) years.<br/>The Trust was looking for a partner that will;<br/>* Provide an exceptional, high-quality service that meets the specialist needs of a<br/>comprehensive cancer centre;<br/>* Provide investment for the provision of world class infrastructure;<br/>* Embrace the exciting opportunities presented with the co-location of a world leading<br/>oncology research centre; and<br/>* Provide expert guidance along with the creativity and drive to deliver a modern, thriving,<br/>truly exceptional pathology service for patients.",
        "lots": [
            {
                "id": "1",
                "description": "The current pathology service provides routine and specialist pathology services with c100 dedicated staff on The Christie Hospital site. The service includes translational biomarker development and supports the Trust's ambitious Research and Innovation (R&I) programme and clinical trials portfolio.<br/><br/>Demand for testing is increasing year on year reflecting the Trust's oncology case load. The Trust sought a JV pathology partner who is able to deliver the Trust's strategic ambitions, including accommodation of projected testing growth demand and flexible options for the development of facilities, estate, technology, and changes in clinical pathways.<br/><br/>Vision<br/>To provide a world leading comprehensive pathology service that supports timely and highquality<br/>delivery of patient care - regionally and nationally - and develops an internationally recognised workforce who, with academic and industry partners, deliver a pioneering<br/>programme of research and innovation.<br/><br/>Principles/Objectives<br/>The Future Pathology Service should reflect the following principles/objectives:<br/><br/>* Safe, effective, and responsive to the diversity of patient and clinical needs and offers the specialist and integrated pathology services needed to support a regional tertiary cancer centre.<br/>* Delivery of a sustainable future pathology workforce<br/>* alignment with the Trust's Vision and Values and the objectives of Greater Manchester Cancer.<br/>* Commitment to working as part of Greater Manchester ICS in the delivery of the Core20PLUS5 programme to support the reduction of health inequalities at both national and system level.<br/>* Enabled by a strong digital infrastructure and capability. Adopting digital opportunity and technology advances to deliver more efficient and scalable pathology services.<br/>* A service model that considers The Trust's local, regional national and international partnerships, including engagement with the Greater Manchester Pathology Network to<br/>explore opportunities to support system requirements.<br/>* Delivered through a partnership that has a strategy for profitable growth through expanding test repertoire and customer base.<br/>* Builds upon the Trust's reputation as an international leader in research and innovation, which is further strengthened by being a partner in the Manchester Cancer Research Centre<br/>(MCRC) and Health Innovation Manchester.<br/>* A service with capital investment to provide best in class facilities.<br/>* A service that has education at its core.<br/><br/>The Future Operating Model for Pathology must include:<br/><br/>* An end-to-end comprehensive pathology service<br/>* Blood sciences including haematology, blood transfusion, clinical biochemistry and immunoassay<br/>* On-site essential services laboratory to support time critical and pathway critical services<br/>* Histopathology (including immunohistochemistry and receptor analysis)<br/>* Stem Cell Laboratory<br/>* Point-of-Care Testing<br/>* A future-proof design with activity growth in service expectation factored in - including expansion of on-site and off-site facilities to meet projected demand;<br/>* An agile approach that can respond to evolving technology and operational requirements and provide improvements to the Trust Pathology Estate;<br/>* Training, Development and Education, Research and Innovation<br/>* Positive workplace culture<br/>* IT infrastructure and digital enablement (including Digital Histopathology)<br/>* Best in class equipment and instrumentation",
                "status": "cancelled",
                "value": {
                    "amount": 240000000,
                    "currency": "GBP"
                },
                "contractPeriod": {
                    "durationInDays": 7200
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "The proposed contract is to be let for an initial term of 180 months. There is also an option to extend the Contract by up to a further 60 months following the initial term."
                },
                "secondStage": {
                    "minimumCandidates": 3,
                    "maximumCandidates": 3
                },
                "selectionCriteria": {
                    "description": "As specified in the SQ/ITPD documentation"
                },
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": false,
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Clinical / Operational",
                            "type": "quality",
                            "description": "13"
                        },
                        {
                            "name": "Quality and Safety",
                            "type": "quality",
                            "description": "5"
                        },
                        {
                            "name": "Implementation",
                            "type": "quality",
                            "description": "4.8"
                        },
                        {
                            "name": "Future-proofing",
                            "type": "quality",
                            "description": "4.8"
                        },
                        {
                            "name": "Research & Innovation",
                            "type": "quality",
                            "description": "4.2"
                        },
                        {
                            "name": "Workforce",
                            "type": "quality",
                            "description": "8"
                        },
                        {
                            "name": "I&MT",
                            "type": "quality",
                            "description": "8"
                        },
                        {
                            "name": "Strategy, Risk & Governance",
                            "type": "quality",
                            "description": "7.2"
                        },
                        {
                            "name": "Social Value",
                            "type": "quality",
                            "description": "10"
                        },
                        {
                            "name": "Legal",
                            "type": "quality",
                            "description": "5"
                        },
                        {
                            "type": "price",
                            "description": "30"
                        }
                    ]
                }
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85110000",
                        "description": "Hospital and related services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "85111810",
                        "description": "Blood analysis services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKD"
                    },
                    {
                        "region": "UKD3"
                    },
                    {
                        "region": "UKD3"
                    },
                    {
                        "region": "UKD3"
                    },
                    {
                        "region": "UKD3"
                    },
                    {
                        "region": "UKD3"
                    },
                    {
                        "region": "UKD3"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2023-05-01T00:00:00+01:00",
            "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
        },
        "coveredBy": [
            "GPA"
        ],
        "amendments": [
            {
                "id": "1",
                "unstructuredChanges": [
                    {
                        "oldValue": {
                            "text": "The new partnership will need to provide the following: * A Blood Sciences Essential Services Laboratory (ESL) to achieve rapid turnaround time necessary for clinical pathways and patient flow, ideally on site to facilitate tight turnaround times, and; * Core Clinical Biochemistry, immunoassay and haematology testing within the ESL to be fully automated, enabling rapid turnaround of test results through pathology workflow efficiencies."
                        },
                        "newValue": {
                            "text": "The new partnership will need to provide the following: * A Blood Sciences Essential Services Laboratory (ESL) to achieve rapid turnaround time necessary for clinical pathways and patient flow, ideally on site to facilitate tight turnaround times, and; * Core Clinical Biochemistry, immunoassay and haematology testing within the ESL to be fully automated, enabling rapid turnaround of test results through pathology workflow efficiencies. * Histopathology * Molecular Diagnostics * Breast and Gastro-oesophageal Tumour Receptors * Bereavement and Mortuary. The Blood Sciences laboratory includes Clinical Biochemistry, Haematology, Blood Transfusion and Stem Cell. Research and innovation including Blood Sciences Translational Biomarker lab and, Academic Histopathology. IT infrastructure and digital capability. LIMS infrastructure and integration of Digital Pathology and opportunities to apply Artificial Intelligence/Machine Learning to support diagnostic processes/predictive algorithms across Histopathology and Blood Sciences. Business Intelligence capability to optimise performance monitoring and service workflow/workforce, and demand/capacity modelling. Exploration of Microbiology and Virology services (currently outsourced)."
                        },
                        "where": {
                            "section": "II.2.4",
                            "label": "Description of the procurement"
                        }
                    }
                ]
            }
        ],
        "submissionMethod": [
            "electronicSubmission",
            "written"
        ],
        "submissionMethodDetails": "https://health-family.force.com/s/Welcome",
        "documents": [
            {
                "id": "economic",
                "documentType": "economicSelectionCriteria"
            },
            {
                "id": "technical",
                "documentType": "technicalSelectionCriteria"
            }
        ],
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "technical",
                    "description": "Execution of the service is reserved to a particular profession"
                }
            ]
        },
        "procurementMethod": "selective",
        "procurementMethodDetails": "Competitive dialogue",
        "secondStage": {
            "successiveReduction": true,
            "invitationDate": "2023-12-11T00:00:00Z"
        },
        "tenderPeriod": {
            "endDate": "2023-11-27T16:00:00Z"
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 360
            }
        },
        "hasRecurrence": false
    },
    "parties": [
        {
            "id": "GB-FTS-35200",
            "name": "The Christie NHS Foundation Trust",
            "identifier": {
                "legalName": "The Christie NHS Foundation Trust"
            },
            "address": {
                "streetAddress": "The Christie NHS Foundation Trust, Wilmslow Road",
                "locality": "Manchester",
                "region": "UKD3",
                "postalCode": "M20 4BX",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Ms Diane Sinclair",
                "telephone": "+44 7748624560",
                "email": "Diane.Sinclair@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.christie.nhs.uk",
                "buyerProfile": "https://www.christie.nhs.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-40530",
            "name": "The Christie NHS Foundation Trust",
            "identifier": {
                "legalName": "The Christie NHS Foundation Trust"
            },
            "address": {
                "streetAddress": "Wilmslow Road",
                "locality": "Manchester",
                "region": "UKD3",
                "postalCode": "M20 4BX",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Diane Sinclair",
                "telephone": "+44 7748624560",
                "email": "diane.sinclair@nhs.net",
                "url": "https://health-family.force.com/s/Welcome"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.christie.nhs.uk/",
                "buyerProfile": "https://www.christie.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-1661",
            "name": "The High Court",
            "identifier": {
                "legalName": "The High Court"
            },
            "address": {
                "streetAddress": "The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
            }
        },
        {
            "id": "GB-FTS-147363",
            "name": "SYNLAB",
            "identifier": {
                "legalName": "SYNLAB",
                "id": "03216065"
            },
            "address": {
                "streetAddress": "Francis House, 9 King's Head Yard, London.",
                "locality": "London",
                "region": "UKI",
                "postalCode": "SE1 1NA",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "amy.davenport@synlab.co.uk"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "url": "http://www.synlab.co.uk",
                "scale": "sme"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-40530",
        "name": "The Christie NHS Foundation Trust"
    },
    "language": "en",
    "description": "The proposed contract is to be let for an initial term of 180 months. There is also an option to extend the Contract by up to a further 60 months following the initial term.",
    "awards": [
        {
            "id": "020538-2025-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-147363",
                    "name": "SYNLAB"
                }
            ]
        },
        {
            "id": "020539-2025-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-147363",
                    "name": "SYNLAB"
                }
            ]
        },
        {
            "id": "020542-2025-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-147363",
                    "name": "SYNLAB"
                }
            ]
        },
        {
            "id": "020560-2025-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-147363",
                    "name": "SYNLAB"
                }
            ]
        },
        {
            "id": "020567-2025-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-147363",
                    "name": "SYNLAB"
                }
            ]
        }
    ],
    "contracts": [
        {
            "id": "020538-2025-1",
            "awardID": "020538-2025-1",
            "status": "active",
            "value": {
                "amount": 200000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-05-12T00:00:00+01:00"
        },
        {
            "id": "020539-2025-1",
            "awardID": "020539-2025-1",
            "status": "active",
            "value": {
                "amount": 200000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-05-12T00:00:00+01:00"
        },
        {
            "id": "020542-2025-1",
            "awardID": "020542-2025-1",
            "status": "active",
            "value": {
                "amount": 200000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-05-12T00:00:00+01:00"
        },
        {
            "id": "020560-2025-1",
            "awardID": "020560-2025-1",
            "status": "active",
            "value": {
                "amount": 200000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-05-12T00:00:00+01:00"
        },
        {
            "id": "020567-2025-1",
            "awardID": "020567-2025-1",
            "status": "active",
            "value": {
                "amount": 200000000,
                "currency": "GBP"
            },
            "dateSigned": "2025-05-12T00:00:00+01:00"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "11",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "12",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "13",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "14",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "15",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "16",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "17",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "18",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "19",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "20",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 1
            }
        ]
    }
}